Evidence map›Paper›PMID 32943763›Full record

ArticleInternational journal of obesity (2005)2021

Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery.

Pablo J Giraudi, Michela Giuricin, Deborah Bonazza, Nicolò de Manzini, Claudio Tiribelli, Silvia Palmisano, Natalia Rosso

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Comparative Proteomic Analysis of Liver Tissues and Serum inInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pablo J GiraudiFondazione Italiana Fegato, Centro Studi Fegato, Area Science Park Basovizza Bldg. Q SS14 Km 163.5, Trieste, Italy. pablo.giraudi@fegato.it.ORCID http://orcid.org/0000-0003-2852-6648
Michela GiuricinUCO Clinica Chirurgica, Ospedale di Cattinara, Strada di Fiume, 447, Trieste, Italy.
Deborah BonazzaUCO Anatomia e Istologia Patologica, Ospedale di Cattinara, Strada di Fiume, 447, Trieste, Italy.ORCID http://orcid.org/0000-0002-5605-6711
Nicolò de ManziniUCO Clinica Chirurgica, Ospedale di Cattinara, Strada di Fiume, 447, Trieste, Italy.
Claudio TiribelliFondazione Italiana Fegato, Centro Studi Fegato, Area Science Park Basovizza Bldg. Q SS14 Km 163.5, Trieste, Italy.
Silvia Palmisano *Fondazione Italiana Fegato, Centro Studi Fegato, Area Science Park Basovizza Bldg. Q SS14 Km 163.5, Trieste, Italy.
Natalia Rosso *Fondazione Italiana Fegato, Centro Studi Fegato, Area Science Park Basovizza Bldg. Q SS14 Km 163.5, Trieste, Italy.
Fondazione Italiana Fegato · ITOspedale di Cattinara · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNonalcoholic fatty liver disease (NAFLD) is strictly associated with the epidemic of obesity and is becoming the most prevalent liver disease worldwide. In severe obesity, bariatric surgery (BS) is the most effective treatment not only for obesity but also for the associated metabolic co-morbidities, NAFLD, among others. To date, noninvasive diagnostic/prognostic methods cannot evaluate hepatic improvements following surgery.

objectivesWe aimed to measure plasma level of insulin-growth factor-2 protein (IGF2) and epithermal growth factor receptor (EGFR), and to assess their relationship with clinical and biochemical parameters during the 12 months follow-up.

methodsDemographic, clinical-biochemical data, and plasma IGF2 and EGFR were measured in 69 patients preoperatively (T0) and 6 and 12 months (T6M and T12M, respectively) after BS. Liver biopsy was performed at T0. Relationships between IGF2, EGFR, and several biochemical parameters were performed using Pearson or Spearman correlation analysis.

resultsIGF2 plasma level increases during follow-up, passing from 2.5 (1.8-15.5) at baseline to 13.3 (8.6-19.1) at T12M, p < 0.001. Conversely, EGFR showed a not significant reduction. At T12M, the plasma level of both markers was comparable to those of lean subjects. The clinical-biochemical parameters (BMI, glycated hemoglobin, HOMA-IR) also return to the normal range at T12M. Correlation analysis demonstrated that IGF2 was significantly associated with total bilirubin, direct bilirubin, and albumin at T0 while with blood glucose, ALT, GGT, and AST/ALT ratio at T6M and T12M.

conclusionsIGF2 plasma levels increase after bariatric surgery, and these changes are associated with the modification of hepatic biochemical parameters, even if other clinic or metabolic improvements cannot be excluded.

Indexed as

Non-alcoholic Fatty Liver DiseaseObesity, MorbidAdultBariatric SurgeryErbB ReceptorsFemaleHumansInsulin-Like Growth Factor IIMaleMiddle AgedTreatment OutcomeEGFR protein, humanErbB ReceptorsIGF2 protein, humanInsulin-Like Growth Factor II

Identifiers

PMID32943763
OpenAlexW3087283894

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.